• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Sesquiterpene lactones
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Terpene lactones Sesquiterpene lactones

Parthenolide (CAS No. 29552-41-8): A Comprehensive Overview of Its Properties, Applications, and Research Advancements

Parthenolide, a naturally occurring sesquiterpene lactone with the CAS number 29552-41-8, has garnered significant attention in recent years due to its diverse biological activities and potential therapeutic applications. This compound is primarily derived from feverfew (Tanacetum parthenium), a traditional medicinal herb. Researchers have extensively studied Parthenolide for its anti-inflammatory, anti-cancer, and immunomodulatory properties, making it a subject of interest in both academic and industrial settings.

One of the most compelling aspects of Parthenolide is its ability to modulate key cellular pathways, including the NF-κB signaling pathway, which plays a critical role in inflammation and cancer progression. Studies have shown that Parthenolide can inhibit the activation of NF-κB, thereby reducing the production of pro-inflammatory cytokines and promoting apoptosis in cancer cells. This mechanism has sparked interest in its potential as a natural anti-cancer agent, particularly in the context of leukemia and breast cancer.

In addition to its anti-cancer properties, Parthenolide has demonstrated efficacy in managing migraine headaches, a condition for which feverfew has been traditionally used. Clinical trials have explored its ability to reduce the frequency and severity of migraines, with promising results. This has led to increased consumer interest in Parthenolide supplements as a natural alternative to conventional migraine medications.

The compound's anti-inflammatory effects extend beyond migraines. Recent research has investigated its potential in treating chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (IBD). By targeting multiple inflammatory pathways, Parthenolide offers a multi-faceted approach to inflammation management, distinguishing it from single-target pharmaceuticals.

From a chemical perspective, Parthenolide (CAS 29552-41-8) features a unique structure with an α-methylene-γ-lactone moiety, which is responsible for its biological activity. This structural motif enables the compound to interact with thiol groups in proteins, leading to the modulation of various cellular processes. The compound's structure-activity relationship (SAR) has been a focus of medicinal chemistry research, with efforts to develop derivatives with improved bioavailability and potency.

In the realm of natural product research, Parthenolide stands out as a prime example of how traditional medicine can inform modern drug discovery. The compound's journey from a folk remedy to a subject of rigorous scientific investigation highlights the importance of ethnopharmacology in identifying bioactive molecules. This intersection of traditional knowledge and contemporary science resonates with growing consumer interest in plant-based therapeutics and holistic health approaches.

Recent advancements in extraction and purification techniques have improved the accessibility of high-purity Parthenolide for research and commercial applications. Supercritical fluid extraction (SFE) and advanced chromatographic methods have enabled the production of standardized extracts with consistent Parthenolide content, addressing previous challenges related to variability in natural sources.

The safety profile of Parthenolide has been another area of investigation. While generally well-tolerated at therapeutic doses, researchers continue to explore its pharmacokinetics and toxicity to establish optimal dosing regimens. This research is particularly important as interest grows in developing Parthenolide-based formulations for various health applications.

In the context of personalized medicine, Parthenolide presents interesting possibilities. Its ability to target specific molecular pathways suggests potential for tailored therapeutic approaches based on individual genetic profiles. This aligns with current trends in precision medicine and the search for compounds that can address the underlying mechanisms of disease rather than just symptoms.

The commercial landscape for Parthenolide has evolved significantly, with applications expanding beyond pharmaceuticals into cosmeceuticals and nutraceuticals. Its anti-inflammatory and antioxidant properties make it attractive for skincare formulations targeting conditions like acne and aging. Meanwhile, the dietary supplement market has seen growing demand for feverfew extracts standardized to Parthenolide content, reflecting consumer interest in natural health products.

Looking ahead, research on Parthenolide (CAS 29552-41-8) continues to uncover new potential applications. Recent studies have explored its effects on neurodegenerative diseases, with preliminary evidence suggesting neuroprotective properties. Other investigations have examined its role in metabolic disorders and infectious diseases, broadening the scope of its therapeutic potential.

In conclusion, Parthenolide represents a fascinating intersection of traditional medicine and modern science. With its diverse biological activities and growing body of research supporting its therapeutic potential, this compound continues to captivate researchers, healthcare professionals, and consumers alike. As scientific understanding of its mechanisms deepens and extraction technologies advance, Parthenolide is poised to play an increasingly important role in various health-related applications.

• 20554-84-1(Parthenolide)
• 12650-69-0(Mupirocin)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)